tirzepatide hfpef SUMMIT: Benefits From Similar By Sex in Patients With Obesity-Related ๐ New research in obesity
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 1 - Aug 6
Live Spec
New research in obesity & heart failure The SUMMIT study looked at tirzepatide, a once weekly injection, in people with both obesity and heart failure with preserved ejection fraction (HFpEF). Over 52 Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management AbdulHafez 2026 Endocrinology, Diabetes & Metabolism Wiley Online Library Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction ScienceDirect At #ACC25, Dr. Milton Packer and colleagues present a new secondary analysis from the SUMMIT trial evaluating the effect of tirzepatide in patients with obesity, #HFpEF, and CKD. The trial demonstrated that # Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification Based Analysis JACC
Store: oogcentrumvisie.be ยท Domain: oogcentrumvisie.be


























